Yu Darvish downplays retirement talk after elbow surgery

San Diego Padres pitcher Yu Darvish has stated that talk of his retirement is premature while he recovers from elbow surgery that will sideline him for the entire 2026 season. The 39-year-old is leaning toward voiding his contract but remains focused on rehabilitation.

Yu Darvish Addresses Retirement Speculation

Yu Darvish, the Osaka native and San Diego Padres right-hander, has pushed back against retirement rumors on social media platform X. He indicated he is "leaning toward" voiding his contract with the club, though finer details remain undecided. Darvish signed a six-year extension with the Padres before the 2023 season, leaving three years and $46 million on the deal.

"Right now I am fully focused on my rehab for my elbow, and if I get to a point where I can throw again, I will start from scratch again to compete. If once I get to that point I feel I can’t do that, I will announce my retirement," Darvish wrote. In a Japanese post, he added plans to conduct some rehabilitation at San Diego's Petco Park and attend part of spring training.

The 39-year-old was responding to a San Diego Union-Tribune report claiming he does not intend to pitch in MLB again. In 2025, Darvish started just 15 games for the Padres, going 5-5 with a 5.38 ERA—his worst mark in a 13-year MLB career.

Across 297 career starts, he holds a 115-93 record with a 3.65 ERA and 2,075 strikeouts—a record for Japanese pitchers in MLB—over 1,778 innings with the Texas Rangers, Chicago Cubs, Los Angeles Dodgers, and Padres.

Before joining MLB, Darvish starred for the Hokkaido Nippon Ham Fighters over seven seasons, compiling a 93-38 record and 1.99 ERA. In 2007, he went 15-5 with a 1.82 ERA, earning the Sawamura Award as Japan's top pitcher.

Darvish's future hinges on his elbow recovery progress.

Relaterede artikler

Orioles pitcher Zach Eflin exits mound early in debut, holding right elbow in discomfort vs. Rangers at Camden Yards.
Billede genereret af AI

Zach Eflin exits Orioles debut early with elbow discomfort

Rapporteret af AI Billede genereret af AI

Baltimore Orioles right-hander Zach Eflin departed his 2026 season debut against the Texas Rangers with right elbow discomfort during the top of the fourth inning at Camden Yards. Eflin had recorded seven strikeouts over 3 2/3 innings, allowing one run on Ezequiel Duran's leadoff home run in the third. Rangers starter Jacob deGrom permitted three runs, including a solo home run by Pete Alonso.

The San Diego Padres placed right-hander Yu Darvish on the restricted list Wednesday, finalizing their 26-man roster ahead of Thursday's season opener against the Detroit Tigers at Petco Park. This follows Darvish's January refutation of retirement rumors, where he indicated he was leaning toward voiding his contract while focusing on elbow rehab. Recovering from right elbow surgery, Darvish will miss the 2026 season, freeing a spot on the 40-man roster and potentially $15 million in payroll.

Rapporteret af AI

Detroit Tigers left-hander Tarik Skubal will undergo surgery to remove loose bodies from his elbow after the team announced the procedure on Monday. The two-time Cy Young winner is expected to miss two to three months, raising questions about his performance and contract value heading into free agency after the 2026 season.

Houston Astros pitcher Tatsuya Imai, sidelined with arm fatigue, said tests showed no significant injury and pointed to challenges adjusting to life in the United States. The Japanese right-hander, in his first MLB season, noted differences in travel and eating habits compared to Japan. He expects to build arm strength and return soon.

Rapporteret af AI

Los Angeles Dodgers pitcher Roki Sasaki delivered a promising performance in his first start of the 2026 season, allowing one earned run over four innings against the Cleveland Guardians. The Dodgers fell 4-2 in their first loss of the year. Manager Dave Roberts praised Sasaki's response after a tough spring training.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis